KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Asset Writedowns and Impairment (2023 - 2026)

Supernus Pharmaceuticals has reported Asset Writedowns and Impairment over the past 3 years, most recently at -$1.2 million for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 117.84% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Sep 2025, down 63.45% year-over-year, with the annual reading at $8.9 million for FY2024, 56.06% down from the prior year.
  • Asset Writedowns and Impairment was -$1.2 million for Q4 2025 at Supernus Pharmaceuticals, down from -$239000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $20.2 million in Q4 2023 and troughed at -$1.2 million in Q4 2025.
  • The 3-year median for Asset Writedowns and Impairment is $730000.0 (2024), against an average of $3.2 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 25.07% in 2025 against a maximum downside of 724.14% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $20.2 million in 2023, then plummeted by 65.93% to $6.9 million in 2024, then plummeted by 117.84% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Asset Writedowns and Impairment are -$1.2 million (Q4 2025), -$239000.0 (Q3 2025), and $920000.0 (Q2 2025).